@article{c4733fc4c354480db01a31d2360767fc,
title = "Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells",
abstract = "The tumor suppressor p53 functions by inducing the transcription of a collection of target genes. We previously attempted to identify p53 target genes by microarray expression and ChIP-sequencing analyses. In this study, we describe a novel p53 target gene, FUCA1, which encodes a fucosidase. Although fucosidase, α-l-1 (FUCA1) has been reported to be a lysosomal protein, we detected it outside of lysosomes and observed that its activity is highest at physiological pH. As there is a reported association between fucosylation and tumorigenesis, we investigated the potential role of FUCA1 in cancer. We found that overexpression of FUCA1, but not a mutant defective in enzyme activity, suppressed the growth of cancer cells and induced cell death. Furthermore, we showed that FUCA1 reduced fucosylation and activation of epidermal growth factor receptor, and concomitantly suppressed epidermal growth factor signaling pathways. FUCA1 loss-of-function mutations are found in several cancers, its expression is reduced in cancers of the large intestine, and low FUCA1 expression is associated with poorer prognosis in several cancers. These results show that protein defucosylation mediated by FUCA1 is involved in tumor suppression.",
keywords = "EGFR, FUCA1, fucosidase, fucosylation, p53",
author = "Issei Ezawa and Yuichiro Sawai and Tatsuya Kawase and Atsushi Okabe and Shuichi Tsutsumi and Hitoshi Ichikawa and Yuka Kobayashi and Fumio Tashiro and Hideo Namiki and Tadashi Kondo and Kentaro Semba and Hiroyuki Aburatani and Yoichi Taya and Hitoshi Nakagama and Rieko Ohki",
note = "Funding Information: We thank Marc Lamphier for critical reading of the manuscript. This study was partly supported by a Grant-in-Aid for Scientific Research (C) (#26430133, to R.O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labor and Welfare (to R.O.), the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)/Ministry of Education, Culture, Sports, Science and Technology of Japan (to R.O.), the Takeda Science Foundation (to R.O.), Astellas Foundation for Research on Metabolic Disorders (to R.O.), Daiichi-Sankyo Foundation of Life Science (to R.O.), Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University (to R.O.), and Cooperative Research Program of Institute for Frontier Medical Sciences, Kyoto University (to R.O.). Publisher Copyright: {\textcopyright} 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.",
year = "2016",
month = jun,
day = "1",
doi = "10.1111/cas.12933",
language = "English",
volume = "107",
pages = "734--745",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "6",
}